CompletedNot Applicable

Repetitive Transcranial Magnetic Stimulation in Amphetamine Addiction

Taiwan5 participantsStarted 2022-02-17

Plain-language summary

The study aims to test whether transcranial magnetic stimulation (TMS) improves the craving, depression, anxiety and cognitive function during the abstinent period of methamphetamine users.

Who can participate

Age range20 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Age ranged 20-65.
✓. Under judicially supervised outpatient-based methamphetamine abuse treatment program

Exclusion criteria

✕. Major disorders other than substance use disorders in Diagnostic and Statistics Manual-5 (e.g. Schizophrenia, organic brain syndrome, and bipolar disorders).
✕. Epilepsy, head trauma, migraine, cardiovascular comorbidity, atypical parkinsonian disorder
✕. patients with heart pacemakers, implanted drug delivery aids, artificial electronic ears, implantable defibrillators, and/or implanted nerve stimulators, and near the implants mentioned above.
✕. patients who have metal implants in their bodies, as well as those with metal implants.
✕. people who have damaged skin in areas of the patient's body that receive stimulation.
✕. patients with multiple sclerosis.
✕. patients who have extensive ischemic scarring.
✕. pregnant women.

What they're measuring

Visual analogue scale (Taiwanese version)

Timeframe: 20 weeks

Trial details

NCT IDNCT04993300

SponsorNational Taiwan University Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-08-04

View on ClinicalTrials.gov More Craving trials